Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclin D1 expression in gliomas

P Cavalla1, A Dutto, R Piva

  • 1Department of Neuroscience, University of Turin, Italy.

Acta Neuropathologica
|March 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Added value of spinal cord MRI in detecting active disease in non-relapsing progressive multiple sclerosis patients.

Journal of neurology·2025
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.

Journal of neurology·2021
Same author

A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia.

Journal of the neurological sciences·2021
Same author

Informing MS patients on treatment options: a consensus on the process of consent taking.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2020
Same author

Listening to the neurological teams for multiple sclerosis: the SMART project.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2020
Same journal

CTE-type tau filaments in Alzheimer's disease with co-morbid LATE-NC.

Acta neuropathologica·2026
Same journal

Mutation-specific neuropathologic signatures in MAPT-associated frontotemporal lobar degeneration.

Acta neuropathologica·2026
Same journal

Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.

Acta neuropathologica·2026
Same journal

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026
Same journal

Inhibition of tRNA fragments dysregulated in human mTLE exacerbates pathology and seizure activity.

Acta neuropathologica·2026
Same journal

VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy.

Acta neuropathologica·2026
See all related articles

Cyclin D1 (cycD1) expression increases with glioma malignancy, correlating with Ki-67 MIB-1 proliferation markers. However, cycD1 staining doesn't confirm gene overexpression, and its role in reactive cells needs further study.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunohistochemistry

Background:

  • Cyclin D1 (cycD1) is a key regulator of the cell cycle.
  • Its expression is often altered in various cancers, including gliomas.
  • Immunohistochemistry is a common method for assessing protein expression in tumor tissues.

Purpose of the Study:

  • To investigate the expression patterns of Cyclin D1 (cycD1) in glioma biopsies.
  • To correlate cycD1 expression with histological malignancy grade and proliferation markers (Ki-67 MIB-1).
  • To evaluate different antibodies for cycD1 detection.

Main Methods:

  • Immunohistochemical analysis of 50 glioma biopsies using two different antibodies (DCS-6 and H-295) for cycD1.
  • Comparison of cycD1 labelling index (LI) with histological grade and Ki-67 MIB-1 LI.

Related Experiment Videos

  • Assessment of cycD1 expression in different tumor areas (invasive vs. solid).

    • Main Results:

    • cycD1 LI increased with glioma histological malignancy, paralleling Ki-67 MIB-1 LI.
    • The antibody H-295 showed higher positive nuclei counts than DCS-6 (3:1 ratio).
    • While cycD1 and MIB-1 LIs showed parallel trends, the correlation was not statistically significant.
    • cycD1 LI was often higher in invasive areas, potentially due to expression in reactive cells.

    Conclusions:

    • Cyclin D1 (cycD1) expression is associated with glioma progression and proliferation.
    • Different antibodies yield varying results for cycD1 detection.
    • cycD1 staining alone does not confirm gene overexpression; other mechanisms of cell cycle deregulation may be involved.
    • The contribution of neoplastic versus reactive cells to cycD1 expression requires further investigation.